AngioDynamics Inc
NASDAQ:ANGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AngioDynamics Inc
NASDAQ:ANGO
|
US |
|
C
|
Cardno Ltd
OTC:COLDF
|
AU |
|
Embla Medical hf
CSE:EMBLA
|
IS |
|
B
|
Bioscience Animal Health PCL
SET:BIS
|
TH |
|
Vital Energy Inc
NYSE:VTLE
|
US |
|
A
|
Aikchol Hospital PCL
SET:AHC
|
TH |
|
S
|
Saha Pathanapibul PCL
SET:SPC
|
TH |
|
Christian Dior SE
PAR:CDI
|
FR |
|
E
|
ELEVAI Labs Inc
NASDAQ:ELAB
|
US |
|
Cromwell Property Group
ASX:CMW
|
AU |
|
Prospect Resources Ltd
ASX:PSC
|
AU |
|
L1 Group Ltd
F:PIJ0
|
AU |
|
P
|
Pc Iletisim ve Medya Hizmetleri Sanayi Ticaret AS
IST:PCILT.E
|
TR |
Wall Street
Price Targets
ANGO Price Targets Summary
AngioDynamics Inc
According to Wall Street analysts, the average 1-year price target for
ANGO
is 19.72 USD
with a low forecast of 16.16 USD and a high forecast of 25.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ANGO's stock price target?
Price Target
19.72
USD
According to Wall Street analysts, the average 1-year price target for
ANGO
is 19.72 USD
with a low forecast of 16.16 USD and a high forecast of 25.2 USD.
What is AngioDynamics Inc's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
AngioDynamics Inc's revenue is
2%.
The projected
CAGR
for the next 3 years is
6%.
